Jagsonpal Pharmaceuticals share news and announcements
NSE: JAGSNPHARMBSE: 507789Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹210.86.
- Next results date: the board meets on 28 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,399 Cr1,360th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- 30.8
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- 5.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.89%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 17.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 18.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 70,16245.8% delivered
Jagsonpal Pharmaceuticals share news and announcements
547 announcements, routine notices left out, newest first. Page 6 of 11.
Apr 2022
Mar 2022
Feb 2022
28 Feb · Legal
The exchange asked on 25 Feb 2022
22 Feb · Disclosure
22 Feb · Business
18 Feb · Updates
11 Feb · Board meeting
Jan 2022
19 Jan · Board meeting
Not held on this date
Dec 2021
29 Dec · Legal
The exchange asked on 28 Dec 2021
Nov 2021
Oct 2021
20 Oct · Corporate action
19 Oct · Business
Sep 2021
7 Sep · Corporate action
Aug 2021
13 Aug · Board meeting
Jul 2021
12 Jul · Legal
The exchange asked on 9 Jul 2021
Jun 2021
9 Jun · Legal
The exchange asked on 4 Jun 2021
May 2021
25 May · Board meeting
14 May · Board meeting
Apr 2021
29 Apr · Legal
The exchange asked on 23 Apr 2021
Feb 2021
12 Feb · Board meeting
Jan 2021
Dec 2020
Nov 2020
19 Nov · Legal
The exchange asked on 18 Nov 2020